Résumé
We propose a new computational method of relating kinase inhibitor protein targets to genetic defects associated to a disease through protein interaction network-based random walks. We illustrate the potential of this methods on two forms of leukemia chronic myeloid and Philadelphia positive acute lymphoblastic.